Takeda introduces the in their shoes experience to the middle east in support of the ibd patient community

Dubai, uae, june 9, 2021 /prnewswire/ -- takeda (tse: 4502) (nyse: tak) has introduced the "in their shoes"  platform, an award-winning, immersive simulation program to promote greater awareness and empathy for patients with inflammatory bowel disease (ibd), a condition to describe crohn's disease and ulcerative colitis, to a group of healthcare providers in the middle east the first time.  the subscription-based program launched with a two-day simulation where healthcare providers and takeda employees learned about the condition most effectively and profoundly: by "living with it.
TAK Ratings Summary
TAK Quant Ranking